0001209191-22-004080.txt : 20220120
0001209191-22-004080.hdr.sgml : 20220120
20220120170048
ACCESSION NUMBER: 0001209191-22-004080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220118
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allen Patricia L
CENTRAL INDEX KEY: 0001348587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 22542978
BUSINESS ADDRESS:
BUSINESS PHONE: 978-687-6988
MAIL ADDRESS:
STREET 1: 7 ASHFORD LANE
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-18
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001348587
Allen Patricia L
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
1
0
0
0
Stock Option (Right to Buy)
8.27
2022-01-18
4
A
0
9570
5.22
A
2032-01-17
Common Stock
9570
9570
D
These options were issued upon election by the director to receive her cash board retainer fee of $50,000 for the FY 2022 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. 2,393 shares will vest on March 31, 2022, 2,393 shares will vest on June 30, 2022, 2,393 shares will vest on September 30, 2022 and the remaining 2,391 shares will vest on December 31, 2022.
/s/ Thomas P. Kelly, Attorney-in-Fact
2022-01-20